However, there is a lack of data on TTF‐1 expression rate in NSCLC patients with PD‐L1 TPS ≥50% and the association between TTF‐1 expression and efficacy of ICI monotherapy in patients with lung adenocarcinoma only. The gene discussed is CD274; the disease is lung adenocarcinoma.